The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HERIZON: A phase 1B/2 open-label study of imu-131 HER2/neu peptide vaccine PLUS standard of care chemotherapy with randomization in phase 2 in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction.
 
Rita Laeufle
Employment - Imugene
Leadership - Imugene
Stock and Other Ownership Interests - Imugene
 
Marina Maglakelidze
No Relationships to Disclose
 
Iurie Bulat
No Relationships to Disclose
 
Dinara Ryspayeva
No Relationships to Disclose
 
Andric Zoran
No Relationships to Disclose
 
Tanuj Chawla
No Relationships to Disclose
 
Ivan Nikolic
No Relationships to Disclose
 
Rajnish Nagarkar
No Relationships to Disclose
 
Giri Venkata
No Relationships to Disclose
 
Vaibhav Choudhary
No Relationships to Disclose
 
Davorin Radosavljevic
No Relationships to Disclose
 
Rajesh Kumar Singh
No Relationships to Disclose
 
Ursula Wiedermann
No Relationships to Disclose
 
Anthony J Good
Employment - Imugene
Leadership - Imugene
Stock and Other Ownership Interests - Imugene
 
Nick Ede
Employment - Imugene
Leadership - Imugene
Stock and Other Ownership Interests - Imugene
 
Leslie Mi Ok Chong
Employment - Imugene
Leadership - Imugene
Stock and Other Ownership Interests - Imugene